Dr. Morrey, Director of the Institute, received a Ph.D. in virology at Utah State University in 1983. From 1984 until 1987, he was a Staff Fellow in the Laboratory of Persistent Viral Diseases, at the NIH Rocky Mountain Laboratories (Hamilton, MT). In this position, he worked on retroviruses that led to future AIDS research. Also during the period of 1981-1984, he founded and ran Physician Services, a clinical diagnostic laboratory. He also founded a company producing instructional videos on recombinant DNA techniques.
Dr. Morrey joined the Institute for Antiviral Research at Utah State University in 1987, and currently is Research Professor in the Department of Animal, Dairy and Veterinary Sciences. He has been the PI many NIH-funded grants and contracts. Dr. Morrey has 122 peer-reviewed publications, in addition to 7 book chapters, and 12 journal review articles, most of which involve the use of laboratory animals to discover therapies for viral diseases of animals and humans. He has co-authored one book entitled, Ethics in Biotechnology, delivered 71 oral presentations, and authored or co-authored 106 posters about his research at national and international meetings. His West Nile virus (WNV) research began a year after the 1999 outbreak in New York City. The research team's first investigation of therapies for WNV in cell culture resulted in a publication in Antiviral Research, which was the most cited article in the journal during the year. Science refers to this research in a news article, "West Nile drugs, vaccine still years away." In recent years, the Morrey lab has focused on the neurological disease caused by viral encephalitides, which has resulted in 33 additional peer-reviewed publications. The Morrey lab has also been investigating therapies for hepatitis B virus (HBV) in a genetically engineered mouse model.